Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease

Archive ouverte

Lapiere, Alexia | Geiger, Mallia | Robert, Véronique | Demarquay, Christelle | Auger, Sandrine | Chadi, Sead | Benadjaoud, Mohamedamine | Fernandes, Gabriel | Milliat, Fabien | Langella, Philippe | Benderitter, Marc | Chatel, Jean-Marc | Semont, Alexandra

Edité par CCSD ; Taylor & Francis -

International audience. Every year, millions of people around the world benefit from radiation therapy to treat cancers localized in the pelvic area. Damage to healthy tissue in the radiation field can cause undesirable toxic effects leading to gastrointestinal complications called pelvic radiation disease. A change in the composition and/or function of the microbiota could contribute to radiation-induced gastrointestinal toxicity. In this study, we tested the prophylactic effect of a new generation of probiotic like Faecalibacterium prausnitzii (F. prausnitzii) on acute radiation-induced colonic lesions. Experiments were carried out in a preclinical model of pelvic radiation disease. Rats were locally irradiated at 29 Gray in the colon resulting in colonic epithelial barrier rupture. Three days before the irradiation and up to 3 d after the irradiation, the F. prausnitzii A2-165 strain was administered daily (intragastrically) to test its putative protective effects. Results showed that prophylactic F. prausnitzii treatment limits radiation-induced para-cellular hyperpermeability, as well as the infiltration of neutrophils (MPO+cells) in the colonic mucosa. Moreover, F. prausnitzii treatment reduced the severity of the morphologicalchange of crypts, but also preserved the pool of Sox-9+ stem/progenitor cells, the proliferating epithelial PCNA+ crypt cells and the Dclk1+/IL-25+ differentiated epithelial tuft cells. The benefit of F. prausnitzii was associated with increased production of IL-18 by colonic crypt epithelial cells. Thus, F. prausnitzii treatment protected the epithelial colonic barrier from colorectal irradiation. Newgeneration probiotics may be promising prophylactic treatments to reduce acute side effects in patients treated with radiation therapy and may improve their quality of life.

Suggestions

Du même auteur

Preclinical study of chronic radiation cystitis and cell therapy treatment

Archive ouverte | Brossard, Clement | CCSD

International audience. Purpose or ObjectiveChronic radiocystitis (CRC) is a consecutive pathology of pelvic irradiation characterized by chronic inflammation occasionally progressing to fibrosis with symptoms such ...

Preclinical study of Chronic radiation cystitis and cell therapy treatment

Archive ouverte | Brossard, Clement | CCSD

International audience. Introduction and aim of the study: Chronic Radiocystitis Cystitis (CRC) is a disease that is sometimes a consequence of pelvic radiotherapy. It is characterized by chronic inflammation, vascu...

From preclinical study of chronic radiation cystitis to cell therapy treatment. Modélisation préclinique de la Cystite Radique Chronique et étude du potentiel thérapeutiqued’un traitement par thérapie cellulaire

Archive ouverte | Brossard, Clement | CCSD

International audience. La cystite radique chronique (CRC) est une pathologie consécutive d’une irradiation de la zone pelvienne. Elle se caractérise par une inflammation chronique évoluant parfois vers une fibrose...

Chargement des enrichissements...